SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-17-003939
Filing Date
2017-04-18
Accepted
2017-04-18 16:15:37
Documents
4
Period of Report
2017-04-18

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a0417_soligenixinc.htm PRE 14A 471926
2 GRAPHIC img_001.jpg GRAPHIC 1082
3 GRAPHIC img_002.jpg GRAPHIC 1024
4 GRAPHIC img_003.jpg GRAPHIC 102603
  Complete submission text file 0001213900-17-003939.txt   617779
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14778 | Film No.: 17767164
SIC: 2834 Pharmaceutical Preparations